Eugene Kandel

11.9k citations
100 papers · 8.6k · 5 hit papers · h-index 37

Impact in

  • Finance top 0.2%
    • Financial Markets and Investment Strategies
  • Accounting top 0.5%
    • Corporate Finance and Governance
    • Auditing, Earnings Management, Governance

Papers in

    • PI3K/AKT/mTOR signaling in cancer 7
    • Financial Markets and Investment Strategies 30
    • Banking stability, regulation, efficiency 11

Eugene Kandel

99 papers receiving 8.2k citations

Eugene Kandel's Hit Papers

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase 2001 · 780 citations
7800+11+22Years since publication2505007501000

Peers

Eugene Kandel
Comparison fields: 5 of 175
  • Finance 2.3k
  • Accounting 2.2k
  • Cancer Research 895
  • General Decision Sciences 115
  • Safety Research 513
Replace John Morgan with:
John Morgan United States
John Moore United States
Michael Ehrmann Germany
Joseph Engelberg United States
Kevin J. Murphy United States
Thomas J. George United States
Gary J. Miller United States
Lu Zhang China
Robert E. Scott United States
Francis Vella United States
Eugene Kandel relative to John Morgan United States John Morgan's profile →
Citations per field
00.5×10.2×
John Morgan · 1×
Citations per year

Countries citing papers authored by Eugene Kandel

Since Specialization
Citations

This map shows the geographic impact of Eugene Kandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Kandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Kandel more than expected).

Fields of papers citing papers by Eugene Kandel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Kandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Kandel. The network helps show where Eugene Kandel may publish in the future.

Co-authors

The 25 scholars most cited alongside Eugene Kandel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eugene Kandel Line = papers co-authored together Eugene Kandel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Peer Pressure and Partnerships
Hit paper breakdown →
19921140
2
Differential Interpretation of Public Signals and Trade in Speculative Markets
Hit paper breakdown →
1995885
3
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
Hit paper breakdown →
2001780
4
The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKB
Hit paper breakdown →
1999767
5
Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria
Hit paper breakdown →
1999576
6
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.
1999460
7 2010309
8 2006276
9 1999255
10 2002238
11 2009180
12 1996158
13 2008119
14 2006117
15 2010110
16 200799
17 200098
18 200697
19 200094
20 201390

About Eugene Kandel

Eugene Kandel is a scholar working on Molecular Biology, Finance, Accounting, Economics and Econometrics and Oncology, having authored 100 papers that have together received 8.6k indexed citations. Recurring topics across this work include Financial Markets and Investment Strategies (30 papers), Corporate Finance and Governance (28 papers), Banking stability, regulation, efficiency (11 papers), Auditing, Earnings Management, Governance (11 papers), Cancer-related Molecular Pathways (11 papers), Private Equity and Venture Capital (8 papers), Economic theories and models (7 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Finance (2.3k citations), Accounting (2.2k citations), Cancer Research (895 citations), General Decision Sciences (115 citations) and Safety Research (513 citations). Eugene Kandel has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Nissim Hay, Edward P. Lazear, Neil D. Pearson, Scott Kennedy, Nathan Majewski, Andrei L. Gartel, Kathrin Gottlob, R. Brooks Robey, Pietro Veronesi and Efraim Benmelech. Their work appears in journals such as Cell Cycle, Journal of Financial Economics, PLoS ONE, Molecular and Cellular Biology and Review of Financial Studies.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact